Position in SERA
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$5,011,415
-$166,658 QoQ
Shares Held
2,753,525
+7.9% QoQ
Ownership
6.98%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3
of 46 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SERA Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $874,120,974 across 19 Medical Devices names. SERA ranks #15 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
2,990,059 | $233,912,315 | |
| 2 | ABT |
Abbott Laboratories
|
2,183,521 | $198,132,694 | |
| 3 | BSX |
Boston Scientific Corp
|
3,066,626 | $130,883,596 | |
| 4 | SYK |
Stryker Corp
|
306,201 | $96,404,322 | |
| 5 | EW |
Edwards Lifesciences Corp
|
497,362 | $44,991,365 | |
| 6 | PODD |
Insulet Corp
|
287,840 | $43,823,638 | |
| 7 | DXCM |
Dexcom Inc
|
456,802 | $30,765,613 | |
| 8 | STE |
STERIS plc
|
84,877 | $17,872,549 |
All Filings in SERA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,011,415 | 2,753,525 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $5,178,073 | 2,550,775 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $6,725,112 | 2,279,699 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $6,975,878 | 2,279,699 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $6,169,806 | 2,227,367 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $4,563,200 | 1,240,000 | Shares | Defined | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||